natgillin/translations-raw huggingface dataset:
Hyper-CVAD regimen: CP 300 mg/m2 i.v. (3 timer, q 12 timer), dag 1-3;
Hyper-CVAD regimen: CP 300 mg/m2 i.v. (3 h, q 12 h), days 1-3;
Hyper-CVAD regimen: CP 300 mg/m² i.v. (3 timer, q 12 timer), dag 1-3;
Hyper-CVAD regimen: CP 300 mg/m2 i.v. (3 h, q 12 h), days 1-3;
Hyperaciditet Oral paræstesi Ubehag i maven
Paraesthesia oral Stomach discomfort
Hyperaktivitet (højt aktivitetsniveau, rastløshed)
Hyperactivity (high level of activity, restlessness)
hyperaktivitet (udtalt rastløshed og bevægelse) svaghed, der starter i hænderne og fødderne og efterfølgende bevæger sig ind mod kropsstammen.
hyperactivity (excessive restlessness and movement) weakness beginning in the hands and feet and moving up towards the trunk of the body.
hyperaktivitet (voldsom rastløshed og bevægelse) svaghed, der starter i hænderne og fødderne og efterfølgende bevæger sig ind mod kroppen.
hyperactivity (excessive restlessness and movement) weakness beginning in the hands and feet and moving up towards the trunk of the body
hyperaktivitet (voldsom rastløshed og bevægelse) svaghed, der starter i hænderne og fødderne og efterfølgende bevæger sig ind mod kropsstammen.
hyperactivity (excessive restlessness and movement) weakness beginning in the hands and feet and moving up towards the trunk of the body.
Hyperakusis
Uncommon: hyperacusis
Hyperammonæmi på grund af isovalerianeacidæmi.
hyperammonaemia due to isovaleric acidaemia.
hyperargininaemia ornithine translocase deficiency (hyperornithinaemia-hyperammonaemia homocitrullinuria (HHH) syndrome).
hyperargininaemia; ornithine translocase deficiency (hyperornithinaemia-hyperammonaemia homocitrullinuria (HHH) syndrome).
Hyperbilirubinæ mi, øget alanin aminotransferase, øget aspartat aminotransferase
Hyperbilirubin-aemi a, alanine aminotransferase increased, aspartate aminotransferase increased
Hyperbilirubinæmi
Hyperbilirubin-aemia
Hyperbilirubinæmi
Hyperbilirubinemia
Hyperbilirubinæmi (herunder forhøjet konjugeret bilirubin, forhøjet ukonjugeret blodbilirubin, forhøjet blodbilirubin)
Hyperbilirubinaemia (including increased conjugated bilirubin, increased unconjugated blood bilirubin, increased blood bilirubin)
Hyperbilirubinæmi ses ofte med
Hyperbilirubinaemia is frequent with this
Hyperbilirubinæmi*
Hyperbilirubinaemia
Hyperbilirubinæmi*, abnorme proteinanalyser*, vægtstigning, abnorm blodprøve*, forhøjet C-reaktivt protein
Hyperbilirubinaemia*, Protein analyses abnormal*, Weight increased, Blood test abnormal*, C-reactive protein increased
Hyperbilirubinæmi*, abnorme proteinanalyser*, vægttab, vægtstigning
Hyperbilirubinaemia*, Protein analyses abnormal*, Weight decreased, Weight increased
Hyperbilirubinæmi*, unormale proteinanalyser*, vægtstigning, unormal blodprøve*, forhøjet C-reaktivt protein
Hyperbilirubinaemia*, Protein analyses abnormal*, Weight increased, Blood test abnormal*,C-reactive protein increased
Hyperbilirubinæmi, forhøjet gamma- glutamyltransferase
Hyperbilirubinaemia Gamma- glutamyltransferase increased
hyperbilirubinæmi, hepatomegali
hyperbilirubinaemia, hepatomegaly
Hyperbilirubinæmi, hepatomegali
Hyperbilirubinemia, hepatomegaly
Hyperbilirubinæmi, kolestase, hepatitis, leverskade, leversvigt†
hyperbilirubinemia, cholestasis, hepatitis hepatic injury, hepatic failure
Hyperbilirubinæmi, kolestase, hepatitis, leverskade, leversvigt†
hyperbilirubinemia, cholestasis, hepatitis, hepatic injury, hepatic failure
Hyperbilirubinæmi, kolestase, hepatitis, leverskade, leversvigt†
liver enzymes elevations, hyperbilirubinemia, cholestasis, hepatitis hepatic injury, hepatic failure
Hyperbilirubinæmi, stigning i gamma- glutamyltransferase
Hyperbilirubinaemia, gamma- glutamyltransferase increased
Hyperbilirubinæmi, Unormal leverfunktionstest
Hyperbilirubinaem ia, Liver function test abnormalities
Hyperbilirubinæmi, øget alanin aminotransferase, øget aspartat aminotransferase
Hyperbilirubin- aemia, alanine aminotransferase increased, aspartate aminotransferase increased
Hyperbilirubinæmi1
Hyperbilirubinaemia1
Hyperbilirubinæmi:
Hyperbilirubinemia:
hyperbilirubinæmib
hyperbilirubinaemiab
Hypercalciæmi
Hypercalcaemia
Hypercalcuri
Hypercalciuria
hypercalcæmi
hypercalcaemia
Hypercalcæmi
Hypercalcemia
Hypercalcæmi på grund af malign sygdom
Hypercalcaemia of malignancy
Hypercalcæmi var forbigående og sås hyppigst i de første 3 måneder af behandlingen.
Hypercalcemia was transient and was reported most frequently in the first 3 months of treatment.
Hypercalcæmi ved malign sygdom:
Hypercalcemia of malignancy:
hypercholesterolæmi 1
hypercholesterolaemia1
Hypereosinofil syndrom (HES) og/eller kronisk eosinofil leukæmi (CEL).
Hypereosinophilic syndrome (HES) and/or chronic eosinophilic leukaemia (CEL).
Hyperglycæmi
Hyperglycaemia
Hyperglycæmi, vægttab
Hyperglycaemia, weight decreased
Hyperglycæmi, vægtøgning
Deafness, vertigo, earache
HYPERGLYKÆMI (for højt blodsukker)
HYPERGLYCAEMIA (too high blood sugar levels)
HYPERGLYKÆMI (for lavt blodsukker)
HYPERGLYCAEMIA (high blood sugar levels)
Hyperglykæmi (alle grader) blev rapporteret hos 7,8 % af patienterne, der blev behandlet med ceritinib på tværs af de fire kliniske studier; grad 3 eller 4 blev rapporteret hos 5,0 % af patienterne.
Hyperglycaemia (all grades) was reported in 7.8% of patients treated with ceritinib across the four clinical studies; grade 3 or 4 events were reported in 5.0% of patients.
hyperglykæmi (forhøjet blodsukker) leversteatose (fedtlever)
hyperglycaemia (high sugar levels in the blood) hepatic steatosis (fat in the liver)
Hyperglykæmi (højt blodsukker)
If your blood sugar gets too high
Hyperglykæmi (højt blodsukker) betyder, at din krop ikke har tilstrækkeligt insulin.
Hyperglycaemia (too much sugar in the blood) means that your body does not have enough insulin.
Hyperglykæmi (især rapporteret hos diabetikere)
Hyperglycemia (reported especially in diabetic patients)
Hyperglykæmi (især rapporteret hos diabetikere) Hyponatriæmi SIADH6
Hyperglycaemia (reported especially in diabetic patients) Hyponatraemia SIADH6
Hyperglykæmi Hypofosfatæmi
Hyperglycaemia Hypophosphataemia
Hyperglykæmi kan være forårsaget af: at du ikke tager Humalog BASAL eller andet insulin;
Hyperglycaemia can be brought about by: not taking your Humalog or other insulin;
Hyperglykæmi kan være forårsaget af: at du ikke tager Humalog eller andet insulin;
Hyperglycaemia can be brought about by: not taking your Humalog or other insulin;
Hyperglykæmi kan være forårsaget af: at du ikke tager Humalog Mix25 eller andet insulin;
Hyperglycaemia can be brought about by: not taking your Humalog or other insulin;
Hyperglykæmi kan være forårsaget af: at du ikke tager Humalog Mix50 eller andet insulin;
Hyperglycaemia can be brought about by: not taking your Humalog or other insulin;
Hyperglykæmi kan være forårsaget af: at du ikke tager Liprolog Basal eller andet insulin;
Hyperglycaemia can be brought about by: not taking your Liprolog or other insulin;
Hyperglykæmi kan være forårsaget af: at du ikke tager Liprolog eller andet insulin;
Hyperglycaemia can be brought about by: not taking your Liprolog or other insulin;
Hyperglykæmi kan være forårsaget af: at du ikke tager Liprolog Mix25 eller andet insulin;
Hyperglycaemia can be brought about by: not taking your Liprolog or other insulin;
Hyperglykæmi kan være forårsaget af: at du ikke tager Liprolog Mix50 eller andet insulin;
Hyperglycaemia can be brought about by: not taking your Liprolog or other insulin;
hyperglykæmi og diabetisk ketoacidose.
hyperglycaemia and diabetic ketoacidosis.
Hyperglykæmi*
Hyperglycaemia
hyperglykæmi,
hyperglycaemia,
hyperglykæmi,
neuropathy,
hyperglykæmi,
weight decrease,
Hyperglykæmi, appetitløshed
Hyperglycaemia, anorexia
hyperglykæmi, diabetes mellitus, diabetisk ketoacidose, diabetisk hyperosmolært koma
hyperglycaemia, diabetes mellitus, diabetic ketoacidosis, diabetic hyperosmolar coma
hyperglykæmi, elektrolytforstyrrelser (herunder hypokalcæmi)
Hyperglycaemia Electrolyte imbalance (incl.
hyperglykæmi, hypertriglyceridæmi
Gastrointestinal disorders
Hyperglykæmi, hypoalbuminæmi
Hyperglycaemia, hypoalbuminaemia
Hyperglykæmi, hypomagnesiæmi, hypofosfatæmi
Hyperglycaemia, hypomagnesaemia, hypophosphataemia
hyperglykæmi, vægtstigning, vægttab
hyperglycaemia, weight increased, weight decreased
hyperglykæmi.
hyperglycaemia.
Hyperglykæmi/diabetes mellitus, øget kolesterolniveau, vægttab, nedsat appetit, ændringer i niveau af calcium i blodet
Hyperglycemia/Diabe tes mellitus, cholesterol increased, weight decreased, appetite decreased, changes in blood calcium
Hyperglykæmi/diabetes mellitus, øget kolesterolniveau, vægttab, nedsat appetit, ændringer i niveau af calcium i blodet
Hyperglycemia/Diabetes mellitus, cholesterol increased, weight decreased, appetite decreased, changes in blood calcium
Hyperglykæmi3
Hyperglycaemia3
Hyperglykæmiam
Hyperglycaemiaam
Hyperglykæmi◊, nedsat appetit
All ADRs/Frequency
Hyperglykæmi◊, nedsat appetit
Hyperglycaemia◊, Decreased appetite
Hyperhidrose
Common Hyperhidrosis
hyperhidrose
hyperhydrosis,
Hyperhidrose
Metabolism and nutritional disorders
Hyperhidrose (11 %) var meget almindelig hos patienter, der fik mifamurtid i ukontrollerede studier.
Hyperhidrosis (11%) was very common in patients receiving mifamurtide in uncontrolled studies.
Hyperhidrose (inkl. natlige svedeture)*, udslæt
Hyperhidro sis (incl. night sweats)*, rash
Hyperhidrose (inkl. natlige svedeture)*, udslæt
Hyperhidrosis (incl. night sweats)* , rash
Hyperhidrose Pruritus Udslæt Urticaria
Hyperhidrosis
Hyperhidrose Udslæt
Hyperhidrosis Rash
Hyperhidrose Udslæt
Hyperhydrosis Rash
Hyperhidrose Udslæt Urticaria
Hyperhidrosis Rash Urticaria
Hyperhidrose,
Hyperhidrosis,
Hyperhidrose, erytem
Hyperhidrosis, erythema
Hyperhidrose, erytematøst udslæt, urticaria, nattesved
Hyperhidrosis, Rash erythematous, Urticaria, Night sweats
Hyperhidrose, erytematøst udslæt, urticaria, nattesved
Neurotoxicity, Tremor, Neuralgia, Hypersensitivity reaction, Hypoaesthesia
Hyperhidrose, kontusion, kløeb, udslætb
hyperhidrosis,
hyperhidrose, nattesved, alopeci, akne, tør hud,
Immune system disorders
hyperhidrose, nattesved, alopeci, akne, tør hud,
Musculoskeletal and connective tissue disorders
Hyperhidrose2
Hyperhidrosis2
hyperhidrosie
hyperhydrosis,
hyperhidrosis,
Investigations
Hyperhidrosis, erytematøst udslæt, urticaria, nattesved
Neurotoxicity, Tremor, Neuralgia, Hypersensitivity reaction, Hypoaesthesia
hyperhydrering
polydipsia
Hyperhydrering, diabetisk ketoacidosec,
water intoxication, diabetic ketoacidosisc, hypoglycaemia, polydipsia, blood cholesterol increased
hyperhydreringe, diabetisk ketoacidosee, hypoglykæmi, polydipsi
diabetic ketoacidosise, hypoglycaemia,
Hyperhydrose
Renal disorder
hyperhydrose, alopeci, pruritus, tør hud, seborre
hyperhydrosis, alopecia, pruritus, dry skin, seborrhea
Hyperikum (Hypericum perforatum) (urtemedicin mod depression).
St John’s wort (Hypericum perforatum) (herbal medicine for depression).
Hyperkalciuri, hyperton blære, nefrosklerose, polyp i urinblæren, sten i blæren, uretralblødning, urinvejssygdom
Calculus bladder, hypercalciuria, hypertonic bladder, nephrosclerosis, urethral haemorrhage, urinary bladder polyp, urinary tract disorder
Hyperkalciæmi
Hypercalcaemia
Hyperkalcæmi, hyperglykæmi, forværring af den metaboliske tilstand ved diabetes
Hypercalcaemia, hyperglycaemia, worsening of diabetic metabolic state
hyperkalcæmi, hypermagnesiæmi, hypernatriæmi, vægttab
hypercalcaemia, hypermagnesaemia, hypernatraemia, weight decreased
Hyperkaliæ mi2
Hyperkalaemia2
hyperkaliæmi
Hyperkaelemia
Hyperkaliæmi
Hyperkalemia
Hyperkaliæmi kan medføre døden hos ældre patienter, patienter med nyresvigt, diabetespatienter, patienter, der samtidig bliver behandlet med andre lægemidler, der kan øge kaliumniveauet og/eller patienter med interkurrente hændelser.
Hyperkalaemia may be fatal in the elderly, in patients with renal insufficiency, in diabetic patients, in patients concomitantly treated with other medicinal products that may increase potassium levels, and/or in patients with intercurrent events,.
Hyperkaliæmi*
Hyperkalaemia
Hyperkaliæmi, hyponatriæmi eller Na⁺/K⁺-forhold < 27: Nedsæt doseringsintervallet for Zycortal med 2-3 dage eller øg dosis.
Hyperkalaemia, hyponatremia or Na⁺/K⁺ ratio < 27: Decrease the Zycortal dosing interval by 2–3 days or increase the dose.
Hyperkaliæmi: Som med andre lægemidler, der påvirker renin-angiotensin-aldosteron systemet, kan der opstå hyperkaliæmi under behandling med Irbesartan BMS, specielt i tilfælde af nyrefunktions- nedsættelse, klinisk proteinuri på grund af diabetisk nyresygdom, og/eller hjertefejl.
Hyperkalaemia: as with other medicinal products that affect the renin-angiotensin-aldosterone system, hyperkalaemia may occur during the treatment with Irbesartan BMS, especially in the presence of renal impairment, overt proteinuria due to diabetic renal disease, and/or heart failure.
Hyperkaliæmi: Som med andre lægemidler, der påvirker renin-angiotensin-aldosteron systemet, kan der opstå hyperkaliæmi under behandling med Irbesartan Zentiva, specielt i tilfælde af nyrefunktions- nedsættelse, klinisk proteinuri på grund af diabetisk nyresygdom, og/eller hjertefejl.
Hyperkalaemia: as with other medicinal products that affect the renin-angiotensin-aldosterone system, hyperkalaemia may occur during the treatment with Irbesartan Zentiva, especially in the presence of renal impairment, overt proteinuria due to diabetic renal disease, and/or heart failure.
Hyperkaliæmi: Som med andre lægemidler, der påvirker renin-angiotensin-aldosteronsystemet, kan der opstå hyperkaliæmi under behandling med Aprovel, specielt i tilfælde af nyrefunktionsnedsættelse, klinisk proteinuri på grund af diabetisk nyresygdom og/eller hjertefejl.
Hyperkalaemia: as with other medicinal products that affect the renin-angiotensin-aldosterone system, hyperkalaemia may occur during the treatment with Aprovel, especially in the presence of renal impairment, overt proteinuria due to diabetic renal disease, and/or heart failure.
Hyperkaliæmi: Som med andre lægemidler, der påvirker renin-angiotensin-aldosteronsystemet, kan der opstå hyperkaliæmi under behandling med Irbesartan BMS, specielt i tilfælde af nyrefunktions- nedsættelse, klinisk proteinuri på grund af diabetisk nyresygdom og/eller hjertefejl.
Hyperkalaemia: as with other medicinal products that affect the renin-angiotensin-aldosterone system, hyperkalaemia may occur during the treatment with Irbesartan BMS, especially in the presence of renal impairment, overt proteinuria due to diabetic renal disease, and/or heart failure.
Hyperkaliæmi: Som med andre lægemidler, der påvirker renin-angiotensin-aldosteronsystemet, kan der opstå hyperkaliæmi under behandling med Irbesartan Zentiva, specielt i tilfælde af nyrefunktions- nedsættelse, klinisk proteinuri på grund af diabetisk nyresygdom og/eller hjertefejl.
Hyperkalaemia: as with other medicinal products that affect the renin-angiotensin-aldosterone system, hyperkalaemia may occur during the treatment with Irbesartan Zentiva, especially in the presence of renal impairment, overt proteinuria due to diabetic renal disease, and/or heart failure.
Hyperkaliæmi: Som med andre lægemidler, der påvirker renin-angiotensin-aldosteronsystemet, kan der opstå hyperkaliæmi under behandling med Karvea, specielt i tilfælde af nyrefunktionsnedsættelse, klinisk proteinuri på grund af diabetisk nyresygdom og/eller hjertefejl.
Hyperkalaemia: as with other medicinal products that affect the renin-angiotensin-aldosterone system, hyperkalaemia may occur during the treatment with Karvea, especially in the presence of renal impairment, overt proteinuria due to diabetic renal disease, and/or heart failure.
Hyperkaliæmia
Hyperkalaemiaa
Hyperkalæmi
Hyperkalaemia
Hyperkeratose
Musculoskeleta
Hyperkeratose
Musculoskeletal
Hyperkeratose
terminology*)
hyperkeratose, akne, blister, unormal hårvækst, hudafskalning, hypopigmentation af huden
hyperkeratosis, acne, blister, hair growth abnormal, skin exfolation, skin hypopigmentation
Hyperkinesi, tremor, dysfoni, paræstesi, hypoæstesi, hyperæstesi, nedsat koncentration, somnolens, opmærksomhedsforstyrrelser, dårlig søvnkvalitet
Hyperkinesia, tremor, dysphonia, paresthaesia, hypoaesthesia, hyperaesthesia, concentration impaired, somnolence, disturbance in attention, poor quality of sleep
Hyperkinesis
Hyperkinesias
Hyperkloræmisk acidose.
Hyperchloraemic acidosis.
Hyperkolesterolæmi*
hypercholesterolaemia
Hyperkolesterolæmi, hypertriglyceridæmi, urica, ødem og perifert ødem, dehydrering (ofte forbundet med gastrointestinale symptomer)
Hypercholesterolaemia, hypertriglyceridaemia, gout, oedema and peripheral oedema, dehydration (usually associated with gastrointestinal symptoms) Diabetes mellitus
Hyperkolesterolæmi, hypertriglyceridæmi, urica, ødem og perifert ødem, dehydrering (ofte forbundet med gastrointestinale symptomer).
Hypercholesterolaemia, hypertriglyceridaemia, gout, oedema and peripheral oedema, dehydration (usually associated with gastrointestinal symptoms)
Hyperkolesterolæmi3
hypercholesterolaemia3
Hyperleukocytose blev aldrig behandlet med yderligere kemoterapi og ophørte ved fortsættelse af TRISENOX.
Hyperleukocytosis was never treated with additional chemotherapy and resolved on continuation of TRISENOX.
Hyperleukocytose: Behandling med TRISENOX er blevet sammenkædet med udviklingen af hyperleukocytose (≥ 10 x 103/µl) hos nogle patienter.
Hyperleukocytosis: Treatment with TRISENOX has been associated with the development of hyperleukocytosis (≥ 10 x 103/μl) in some patients.
Hyperlink reference not valid.Følg anvisningerne nedenfor til rekonstitution af dibotermin alfa (rhBMP-2) for applikation på matrix under anvendelse af aseptisk teknik.
Directions: Using aseptic technique, follow the directions below to reconstitute dibotermin alfa (rhBMP-2) for application to the sponges.
hyperlipidæmi
hyperlipaemia
Hyperlipidæmi og forhøjede lipider (triglycerider, cholesterol), ændring i kropsvægt
Hyperlipidaemias and lipid increases (triglycerides, cholesterol); Weight changes
Hyperlipidæmi, nedsat appetit, hypertriglyceridæmi, hypofosfatæmi, hyperglykæmia
Hyperlipidaemia, decreased appetite, hypertriglyceridaemia, hypophosphataemia, hyperglycaemia
Hypermagnesiæmi*, acidose, forstyrrelser i elektrolytbalancen*, væskeophobning, hypochloræmi*, hypovolæmi, hyperchloræmi*, hyperfosfatæmi*, stofskiftesygdom, B-vitaminmangel, B12- vitaminmangel, artritis urica, øget appetit, alkoholintolerans
Hypermagnesaemia*, Acidosis, Electrolyte imbalance*, Fluid overload, Hypochloraemia*, Hypovolaemia, Hyperchloraemia*, Hyperphosphataemia*, Metabolic disorder, Vitamin B complex deficiency, Vitamin B12 deficiency, Gout, Increased appetite, Alcohol intolerance
Hypermagnesiæmi*, acidose, forstyrrelser i elektrolytbalancen*, væskeophobning, hypokloræmi*, hypovolæmi, hyperkloræmi*, hyperfosfatæmi*, stofskiftesygdom, B-vitaminmangel, B12- vitaminmangel, artritis urica, øget appetit, alkoholintolerans
Hyperchloraemia *, Hyperphosphataemia*, Metabolic disorder, Vitamin B complex deficiency, Vitamin B12 deficiency, Gout, Increased appetite, Alcohol intolerance
Hypermagnesiæmi*, acidose, forstyrrelser i elektrolytbalancen*, væskeophobning, hypokloræmi*, hypovolæmi, hyperkloræmi*, hyperfosfatæmi*, stofskiftesygdom, B-vitaminmangel, B12- vitaminmangel, artritis urica, øget appetit, alkoholintolerans
Hypermagnesaemia*, Acidosis, Electrolyte imbalance*, Fluid overload, Hypochloraemia*, Hypovolaemia, Hyperchloraemia*, Hyperphosphataemia*, Metabolic disorder, Vitamin B complex deficiency, Vitamin B12 deficiency, Gout, Increased appetite, Alcohol intolerance
Hypermagnesiæmi*, acidose, forstyrrelser i elektrolytbalancen*, væskeophobning, hypokloræmi*, hypovolæmi, hyperkloræmi*, hyperfosfatæmi*, stofskiftesygdom, B-vitaminmangel, B12-vitaminmangel, artritis urica, øget appetit, alkoholintolerans
Hypermagnesaemia*, Acidosis, Electrolyte imbalance*, Fluid overload, Hypochloraemia*, Hypovolaemia, Hyperchloraemia*, Hyperphosphataemia*, Metabolic disorder, Vitamin B complex deficiency, Vitamin B12 deficiency, Gout, Increased appetite, Alcohol intolerance
Hyperparathyroidisme/Ostetis fibrosa cystica
Hyperparathyroidism/Osteitis fibrosa cystica
Hyperparatyreoidisme er en lidelse, hvor biskjoldbruskkirtlerne på halsen producerer for meget paratyroideahormon (PTH). ”Sekundær” hyperparatyreoidisme betyder, at lidelsen er forårsaget af en anden tilstand.
This is a condition in which the parathyroid glands in the neck produce too much parathyroid hormone (PTH). ‘Secondary’ means that the hyperparathyroidism is caused by another condition.
Hyperparatyreoidisme er en tilstand, hvor biskjoldbruskkirtlerne i halsen danner for meget parathyroidhormon (PTH), hvilket kan føre til knogle- og ledsmerter og deformiteter af arme og ben. ‘Sekundær’ betyder, at lidelsen er forårsaget af en anden sygdomstilstand.
Hyperparathyroidism is a condition in which the parathyroid glands in the neck produce too much parathyroid hormone (PTH), which can lead to bone and joint pain and deformities of the arms and legs. ‘Secondary’ means that it is caused by another condition.
Hyperparatyroidisme
Hyperparathyroidism
Hyperpigmen tering
Hyper- pigmentation
Hyperpigmenteret hud
Skin hyperpigmentation
hyperpigmentering af hud, hypertrikose
kin hyperpigmentation, hypertrichosis
Hyperpigmentering af huden (periokulær), misfarvning af huden
kin hyperpigmentation (periocular), skin discolouration
hyperpigmentering af huden (periokulært)
skin hyperpigmentation (periocular)
Hyperpigmentering af huden,
Blister, Skin ulcer,
Hyperpigmentering af huden,
Pigmentation
Hyperpigmentering i
Skin hyperpigmentation
Hyperplasi af urinblæren sås ikke hos hunde eller aber behandlet med pioglitazon i op til 12 måneder.
Hyperplasia of the urinary bladder was not seen in dogs or monkeys treated with pioglitazone for up to 12 months.
Hyperplasi af urinblæren sås ikke hos hunde eller aber, der var blevet behandlet med pioglitazon i op til 12 måneder.
Hyperplasia of the urinary bladder was not seen in dogs or monkeys treated with pioglitazone for up to 12 months.
Hyperplasi var ikke hyppigere ved gentagne behandlingsforløb, inkl. data for 340 kvinder, som fik op til 4 forløb med ulipristalacetat 5 eller 10 mg, og begrænsede data for 43 kvinder, som fik op til 8 forløb med ulipristalacetat 10 mg.
The incidence of hyperplasia did not increase with repeated treatment courses, including data on 340 women who received up to 4 courses of ulipristal acetate 5 or 10 mg and limited data of 43 women who received up to 8 courses of ulipristal acetate 10 mg.
Hyperprolaktin
Hyperprolactinae
Hyperprolaktinæmi
Clinical efficacy
hyperprolaktinæmia
hyperprolactinaemiaa
hyperprolaktinæmib
hyperprolactinaemiab
hyperseksualite
hypersexuality,
hypersensiti vitet (inklusive angioødem og anafylaksi)
Hypersensitivity (including angioedema and anaphylaxis)
Hypersensitiv reaktion
Hyper- sensitivity reaction
Hypersensitive reaktioner, herunder angioneurotisk ødem og anafylaktiske reaktioner, er blevet rapporteret.
Hypersensitivity reactions, including angioneurotic oedema and anaphylactic reaction, have been reported.
hypersensitivi- tetsreaktioner, f.eks. feber, angioødem og anafylaktisk reaktion /shock
hypersensitivity reactions e.g. fever, angioedema and anaphylactic reaction/shock
Hypersensitivite t
Hypersensitivity
Hypersensitivite t, inklusiv anafylaksi*
Hypersensitivity including anaphylaxis
Hypersensitivitet
Common
Hypersensitivitet
Nocturia, Blood
Hypersensitivitet (G3/4: 0,6%)
Hypersensitivity (G3/4: 0.6%)
Hypersensitivitet (G3/4: 2,5%)
Hypersensitivity (G3/4: 2.5%)
Hypersensitivitet (G3/4: 5,3%)
Hypersensitivity (G3/4: 5.3%)
Hypersensitivitet (inklusive anafylaktiske reaktioner og anafylaktisk chok)
Hypersensitivity (incl. anaphylactic reactions and anaphylactic shock)
hypersensitivitet (inklusive angioødem og anafylaksi)
Hypersensitivity (including angioedema and anaphylaxis)
Hypersensitivitet (såsom udslæt, kløe, rødmen, hævelse af huden)
Hypersensitivity (such as rash, itchy skin, reddening of the skin, swelling of the skin)
Hypersensitivitet (såsom udslæt, kløe, rødmen, hævelse af huden)
Hypersensitivity (such as rash, itchy skin, redening of the skin, swelling of the skin)
Hypersensitivitet og allergiske reaktioner
Hypersensitivity and allergic reactions
Hypersensitivitet og allergiske reaktioner:
Hypersensitivity and allergic disorders:
Hypersensitivitet*
Hypersensitivity